Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160342
Status:
COMPLETED
Last Update Posted:
2008-08-15
First Post:
2005-09-09
Brief Title:
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Study Overview
Official Title:
A Multi-Center Double-Blind Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone in Combination and Alone in Relieving Vasomotor Symptoms in Postmenopausal Women
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a research study to evaluate the effectiveness safety and side effects of several dose levels of esterified estrogens EE and methyltestosterone MT given individually and in combination compared to a placebo a tablet with no active drug in it as a possible treatment for vasomotor symptoms such as hot flushes and flushing of menopause EE and testosterone are two hormones which are typically deficient in menopausal women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-002887-27 | None | None | None |